Patent · US Active

Perifosine and capecitabine as a combined treatment for cancer

US8383607B2 · kind B2 · utility

0Cited by

9References

25Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Enrique Poradosu · Brookline, US
Peeter Sportelli · North Andover, US

Key dates

Filing date	Mar 31, 2011
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Mar 31, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Treatment regimens comprising co-treatment of cancer with perifosine and capecitabine are disclosed herein, as well as pharmaceutical compositions and unit dosage forms thereof formulated to be suitable for use in said treatment regimens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.